Reports linking sweat gland-blocking aluminum in antiperspirants to breast cancer led the FDA in 2004 to require warning labels about the potential health dangers of aluminum in antiperspirants. The FDA also warned people with renal (kidney) dysfunction to avoid aluminum-containing antiperspirants, carrying the implication that aluminum-based compounds are indeed absorbed into the body when applied to the skin.
Although drug companies, federal regulatory agencies and medical trade groups state there is no need to throw out antiperspirants, the fact remains that the link between aluminum and breast cancer has not been ruled out. NIH’s National Cancer Institute is clear that studies have provided conflicting results and that additional research would be needed to determine if a relationship does or does not exist.
While there is growing concern about the dangers of aluminum absorbed through the skin, there is also growing concern about injecting aluminum into our bodies via vaccines. Aluminum is a recognized neurotoxin that is used as an adjuvant in some inactivated vaccines, even though there has not been adequate toxicity testing. Aluminum been associated with the development of central nervous system dysfunction, including autism and Alzheimer’s disease. A 2017 article in the journal Toxicology expressed safety concerns about aluminum adjuvants in vaccines because of its long-lasting biopersistence within the immune cells of some individuals, and persistent reports of chronic fatigue syndrome, cognitive dysfunction, myalgia, dysautonomia and other autoimmune-inflammatory disorders developing after receipt of aluminum containing vaccines.
Aluminum expert Chris Exley states that it has been common practice for experimental vaccine trials to use aluminum adjuvants as the control or placebo, resulting in many vaccine-related adverse events in the placebo arm of clinical trials that are caused in part or solely by aluminum adjuvants. The use of aluminum containing placebos in pre-licensure vaccine trials can mask the true reactivity of the experimental vaccine.
There is no known biologic need for aluminum in the human body. Aluminum can enter the body through the gastrointestinal tract by ingesting food cooked in aluminum utensils or drinking beverages from aluminum cans, through injected aluminum-containing vaccines or kidney dialysis products, and through the skin with the use of aluminum containing antiperspirants. If an individual cannot efficiently excrete aluminum in body fluids, such as sweat and urine, it is deposited in bone, brain, liver, heart, spleen and muscle tissue.